Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | XENEXenon Pharmaceuticals Inc.FY2025 · Dec |
|---|---|
| Revenue | $7.50M |
| Revenue, yoy | — |
| Net income | $345.91M |
| Net income, yoy | −47.6% |
| Net margin | -4,612.1% |
| Free cash flow | $279.92M |
| FCF margin | -3,732.2% |
| EPS, diluted | $4.36 |
Add another company.